3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 1
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Squamous Cell Carcinoma of Head and Neck
3
Skin Neoplasms
3
Neoplasms
3
Lung Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Melanoma
2
Carcinoma, Hepatocellular
2
Turcot syndrome
1
Recurrence
1
Prostatic Neoplasms
1
Peripheral Nervous System Diseases
1
Ovarian Neoplasms
1
Non-small Cell Lung Cancer Metastatic
1
Neoplasm Metastasis
1
Neoadjuvant Therapy
1
Mouth Neoplasms
1
Malignant Ascites
1
Liver Neoplasms
1
Head and Neck Neoplasms
1
Glioma
1
Esophageal Squamous Cell Carcinoma
1
Endometrial Neoplasms
1
Carcinoma, Transitional Cell
1
Carcinoma, Squamous Cell
1
Carcinoma, Small Cell
1
Carcinoma, Endometrioid
1
Carcinoma
1
Interventions
Acupuncture Therapy
8
Exercise
6
Cryotherapy
5
Surveys and Questionnaires
2
Physical Therapy Modalities
2
Low-Level Light Therapy
2
Fish Oils
2
pembrolizumab
1
enfortumab vedotin
1
Yoga
1
Vitamin B Complex
1
Ultrasonic Therapy
1
Thioctic Acid
1
Therapeutic Touch
1
Sodium Chloride
1
Single Person
1
Saline Solution
1
Pain Management
1
Paclitaxel
1
Omacor
1
Music Therapy
1
Methods
1
Massage
1
Magnetic Resonance Spectroscopy
1
Lidocaine
1
Gloves, Surgical
1
Fumigant 93
1
Fatty Acids, Omega-3
1
Exercise Therapy
1
Educational Status
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Peripheral Nervous System Diseases
×
pembrolizumab
×
Clear all
NCT07629700
2026-06-05
ENDEAVOR
University of Florence
Phase NA
Not yet recruiting
40 enrolled